Recombinant Human Insulin-like Growth Factor 2 (Somatomedin A)

• Cat.No.: IGF2-457H
• Product Overview: Recombinant Human Insulin-like Growth Factor 2 (Somatomedin A) is expressed inyeast.

Specification

• Cat. No.: IGF2-457H
• Description: Human IGF-II is a potent mitogen for cells of mesodermal origin. It is composed of 67 amino acid residues, and is 62% homologous with human IGF-I.
• Source: Human IGF-II is produced by genetically engineeredyeast, and purified by sequential chromatography.
• Molecular Weight: 7.5 kDa.
• Biological Activity: The material is active in a receptor-binding assay using a membrane preparation from placenta.
• Purity: Over 95% pure by N-terminal amino acid sequencing, amino acid composition, HPLC analysis, and SDS gel electrophoresis.
• Storage And Reconstitution: Store at +4°C. Reconstitution is best in water or buffer near neutral pH. After reconstitution, storage in aliquots at -80 °C is recommended.

Gene Information

• Gene Name: IGF2 insulin-like growth factor 2 (somatomedin A) [ Homo sapiens ]
• Synonyms: insulin-like growth factor 2 (somatomedin A);INSIGF; pp9974; C11orf43; FLJ22066; FLJ44734; IGF2; insulin-like growth factor 2; IGF-II; somatomedin A; somatomedin-A; insulin-like growth factor II; insulin-like growth factor type 2; putative insulin-like growth factor II associated protein; chromosome 11 open reading frame 43; OTTHUMP00000011157; OTTHUMP00000011018
• Gene ID: 3481
• mRNA Refseq: NM_000612
• Protein Refseq: NP_000603
• MIM: 147470
• UniProt ID: P01344
• Chromosome Location: 11p15.5
• Pathway: Diabetes pathways
• Function: growth factor activity; hormone activity; insulin receptor binding; insulin-like growth factor receptor binding; protein binding